KYNB compared with NTRP: revenue, margins and what each company keeps, and the suppliers and customers both name

KYNBKyntra Bio, Inc.

Mkt capRevenueRevenue

NTRPNextTrip, Inc.

Mkt capRevenueRevenue

Compare

KYNBKyntra Bio, Inc.

NTRPNextTrip, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

KYNBKyntra Bio, Inc.

4.43▼−0.60%· post 4.32

Mkt cap$17.5MRevenue$4MQ1 FY26Revenue$6MFY25

NTRPNextTrip, Inc.

1.16▲+7.61%· post 1.17

ClosedNov 3 '26

Mkt cap$17.6MRevenue$546,687Q2 FY27Revenue$4MFY26

Compare

ClosedNov 3 '26

KYNBKyntra Bio, Inc.

NTRPNextTrip, Inc.

4.43▼−0.60%post 4.32

Price

1.16▲+7.61%post 1.17

$17.5M

Mkt cap

$17.6M

Q1 FY26$4M

Revenue

$546,687Q2 FY27

FY25$6M

Revenue

$4MFY26

KYNB4.43▼−0.60%vsNTRP1.16▲+7.61%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

KYNB: latest quarter is a loss; flow not drawable. NTRP: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only KYNB 10

AZNAstraZeneca AB ("AstraZeneca")customer

—Astellas Pharma Inc. ("Astellas")unlistedsupplier

—Fortis Therapeutics, Inc. ("Fortis")unlistedsupplier

—Shanghai SynTheAll Pharmaceutical Co., Ltd. ("WuXi STA")unlistedsupplier

6 more · KYNB chain ›

Shared 0

No disclosed counterparties: NTRP.

Only NTRP 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

KYNB, solidNTRP, dashed